Liver TransplantationLiver DiseasesLiver FailureGraft RejectionImmunosuppressive AgentsLiver CirrhosisGraft SurvivalEnd Stage Liver DiseaseTacrolimusLiverLiver NeoplasmsKidney TransplantationLiving DonorsTissue DonorsWaiting ListsTissue and Organ ProcurementTreatment OutcomePostoperative ComplicationsTransplantationTransplantsRetrospective StudiesTime FactorsLiver Function TestsTransplantation, HomologousCyclosporineLiver RegenerationFatty LiverMycophenolic AcidImmunosuppressionMicrosomes, LiverLiver Failure, AcuteCadaverRisk FactorsHeart TransplantationHepatitis CCytomegalovirus InfectionsCarcinoma, HepatocellularRecurrenceFollow-Up StudiesHepatic ArteryTransplantation ImmunologyDrug-Induced Liver InjuryHepatectomyDonor SelectionLiver CirculationPortal VeinBiliary AtresiaPostoperative PeriodLiver Cirrhosis, AlcoholicMitochondria, LiverLung TransplantationBiliary Tract DiseasesAntiviral AgentsLiver Diseases, AlcoholicRisk AssessmentIncidenceSurvival RateSurvival AnalysisTransplantation ToleranceProspective StudiesPatient SelectionImmunocompromised HostDrug Therapy, CombinationReoperationAlanine TransaminaseCalcineurinBiopsyCholestasisFatal OutcomeHistocompatibility TestingGanciclovirKaplan-Meier EstimateCholangitis, SclerosingBone Marrow TransplantationBilirubinHepatopulmonary SyndromeLiver ExtractsLiver Neoplasms, ExperimentalOpportunistic InfectionsSeverity of Illness IndexCohort StudiesCytomegalovirusKidneyHepatic VeinsDeathHealth Care RationingLymphoproliferative DisordersHepatitis BBrain DeathMycosesMultivariate AnalysisCreatinineHepatitis C, ChronicLiver AbscessKidney Failure, ChronicSirolimusPrognosisRenal InsufficiencyProportional Hazards ModelsAspergillosis